Emergent BioSolutions Inc. (EBS)
1 Item 5.02 filing since 2026-10-16 · 1 with an open seat · roles: CFO. NYSE. Pharmaceutical Preparations. State: MD.
| Score | Filed | Event | Role | Person | Seat | Summary |
|---|---|---|---|---|---|---|
| 70 | 2026-10-16 | Departure | CFO | subscribers | Open | Emergent BioSolutions Inc. (EBS): CFO Richard Lindahl retired; interim named |
Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works